Please select a Capability in order to start your service request.
SAN DIEGO, CA, Oct. 26, 2015/PRNewswire/ – CareFusion, a BD company (NYSE: BDX), today announced its Vital Signs anesthesia delivery and patient monitoring business has entered into an exclusive agreement with AAM Healthcare to distribute its APA™ video laryngoscope in the U.S. and 12 other countries.
The APA™ video laryngoscope is a handheld, portable device to aid in tracheal intubation. Inspired and designed by clinicians, this is an all-in-one device for both routine and rescue airways that offers interchangeable Macintosh (MAC) and Difficult Airway Blades (DAB). The APA™ video laryngoscope is the first device of its kind to incorporate video into the practice of standard laryngoscopy.
Video laryngoscopy can improve first time intubation compared to standard intubations and can be five times less likely to need to perform an oesophageal intubation.1 The APA™ video laryngoscope offers improved Cormack-Lehane views,2 superior viewing angles compared to direct line of sight3 and an improved view of anatomical structures that are normally difficult or impossible to observe.4
"We are committed to providing our customers with the products they need through the combination of our own R&D efforts and strategic external collaborations," said David Young, vice president and general manager of the Vital Signs business line. "For more than 40 years, Vital Signs has strived to provide innovative and quality products, and the APA™ video laryngoscope is no exception."
The APA™ is intuitive for those familiar with direct laryngoscopy5 and has an innovative guiding mechanism to facilitate difficult intubations.6 The curved angulated blade and the patented prism technology allow clinicians to "look around the corner,"6 resulting in a faster and more successful intubation versus direct laryngoscopy.7
The product was first introduced by Vital Signs at the European Society of Anesthesia in June 2015 in Berlin, Germany. The product is commercially available through CareFusion in the United States, France, Spain, Norway, Denmark, Iceland, Finland, Sweden, United Kingdom, Ireland, Japan, Australia and New Zealand.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit bd.com
For more information on BD, please visit bd.com.